中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2010年
4期
273-277
,共5页
李兰%毕晓峰%徐昕%刘秀云%沈贵华%郭蕾%袁燕玲%王芳%王明荣%杨红鹰
李蘭%畢曉峰%徐昕%劉秀雲%瀋貴華%郭蕾%袁燕玲%王芳%王明榮%楊紅鷹
리란%필효봉%서흔%류수운%침귀화%곽뢰%원연령%왕방%왕명영%양홍응
乳腺肿瘤%E-钙黏附蛋白%p120-连环素蛋白%预后
乳腺腫瘤%E-鈣黏附蛋白%p120-連環素蛋白%預後
유선종류%E-개점부단백%p120-련배소단백%예후
Breast neoplasms%E-cadherin%p120-catenin%Prognosis
目的 比较乳腺浸润性小叶癌(ILC)和浸润性导管癌(IDC)的临床病理学特征,探讨E-钙黏附蛋白(E-cadherin)和p120-连环素蛋白(p120-catenin)在ILC和IDC中的表达差异及意义.方法 中国医学科学院肿瘤医院1999年1月至2006年12月共收治ILC 123例,2000年收治IDC 334例.运用组织微阵列及免疫组织化学染色技术,对123例ILC和334例IDC患者的组织蜡块进行切片,并进行E-cadherin和p120-catenin表达的检测,同时对患者进行随访.结果 ILC和IDC患者的5年无瘤生存率(DFS)分别为61.8%和83.7%(P<0.001),5年总生存率(OS)分别为81.7%和79.1%(P=0.055).在36例ILC和221例IDC患者中,E-cadherin表达缺失率分别为55.6%(20/36)和20.4%(45/221,P<0.001),p120-catenin胞浆表达率分别为66.7%(24/36)和16.3%(36/221,P<0.001).在ILC患者中,p120-catenin胞浆表达与E-cadherin表达缺失相关(P=0.002).ILC和IDC患者中,p120-catenin胞浆表达合并E-cadherin表达缺失的比率分别为55.6%(20/36)和4.1%(9/221,P<0.001).结论 ILC具有不同于IDC的临床病理学特点及预后特征,E-cadherin和p120-catenin的检测有助于ILC和IDC的鉴别诊断.
目的 比較乳腺浸潤性小葉癌(ILC)和浸潤性導管癌(IDC)的臨床病理學特徵,探討E-鈣黏附蛋白(E-cadherin)和p120-連環素蛋白(p120-catenin)在ILC和IDC中的錶達差異及意義.方法 中國醫學科學院腫瘤醫院1999年1月至2006年12月共收治ILC 123例,2000年收治IDC 334例.運用組織微陣列及免疫組織化學染色技術,對123例ILC和334例IDC患者的組織蠟塊進行切片,併進行E-cadherin和p120-catenin錶達的檢測,同時對患者進行隨訪.結果 ILC和IDC患者的5年無瘤生存率(DFS)分彆為61.8%和83.7%(P<0.001),5年總生存率(OS)分彆為81.7%和79.1%(P=0.055).在36例ILC和221例IDC患者中,E-cadherin錶達缺失率分彆為55.6%(20/36)和20.4%(45/221,P<0.001),p120-catenin胞漿錶達率分彆為66.7%(24/36)和16.3%(36/221,P<0.001).在ILC患者中,p120-catenin胞漿錶達與E-cadherin錶達缺失相關(P=0.002).ILC和IDC患者中,p120-catenin胞漿錶達閤併E-cadherin錶達缺失的比率分彆為55.6%(20/36)和4.1%(9/221,P<0.001).結論 ILC具有不同于IDC的臨床病理學特點及預後特徵,E-cadherin和p120-catenin的檢測有助于ILC和IDC的鑒彆診斷.
목적 비교유선침윤성소협암(ILC)화침윤성도관암(IDC)적림상병이학특정,탐토E-개점부단백(E-cadherin)화p120-련배소단백(p120-catenin)재ILC화IDC중적표체차이급의의.방법 중국의학과학원종류의원1999년1월지2006년12월공수치ILC 123례,2000년수치IDC 334례.운용조직미진렬급면역조직화학염색기술,대123례ILC화334례IDC환자적조직사괴진행절편,병진행E-cadherin화p120-catenin표체적검측,동시대환자진행수방.결과 ILC화IDC환자적5년무류생존솔(DFS)분별위61.8%화83.7%(P<0.001),5년총생존솔(OS)분별위81.7%화79.1%(P=0.055).재36례ILC화221례IDC환자중,E-cadherin표체결실솔분별위55.6%(20/36)화20.4%(45/221,P<0.001),p120-catenin포장표체솔분별위66.7%(24/36)화16.3%(36/221,P<0.001).재ILC환자중,p120-catenin포장표체여E-cadherin표체결실상관(P=0.002).ILC화IDC환자중,p120-catenin포장표체합병E-cadherin표체결실적비솔분별위55.6%(20/36)화4.1%(9/221,P<0.001).결론 ILC구유불동우IDC적림상병이학특점급예후특정,E-cadherin화p120-catenin적검측유조우ILC화IDC적감별진단.
Objective To determine how patients with infiltrating lobular carcinoma(ILC)differ from patients with the more common infiltrating ductal carcinoma(IDC),and observe the different expression patterns of E-cadherin and p120-catenin proteins in both ILCs and IDCs.Methods The patients with ILC admitted to our hospital from Jan 1999 to Dec 2006 and patients with IDC from Jan 2000 to Dec 2000 were included in this study.All their pathological slides were reviewed,and their clinical data and treatment variables were analyzed retrospectively.Then the expression patterns of E-cadherin and p120-catenin proteins in both ILCs and IDCs were detected by immunohistochemistry on tissue microarray.Results The 5-year overall survival was 81.7% for ILCs and 79.1% for IDCs(P=0.055).The 5-year disease-free survival was 61.8% for ILCs and 83.7% for IDCs(P<0.001).Cytoplasmic localization of p120-catenin and loss of E-cadherin expression were more common in ILCs than in IDCs.The complete losses of Ecadherin in ILCs and IDCs were 55.6%(20/36)and 20.4%(45/221,P<0.001),respectively.The p120-catenin showed a diffuse cytoplasmic localization in 66.7%(24/36)of ILCs and 16.3%(36/221)of IDCs(P<0.001).Interestingly,the cytoplasmic localization of p120-catenin was clearly associated with the absence of E-cadherin expression in ILCs(P=0.002),cytoplasmic localization of p120-catenin and absence of E-cadherin expression were observed 55.6%(20/36)in ILCs compared with 4.1%(9/221)in IDCs(P<0.001).Conclusion ILC has several specific biological and prognostic characteristics which are different in IDC.Different expression patterns of E-cadherin and p120-catenin proteins can be helpful to recognize ILC from IDC.